Company intelligence / Profile preview

Asiagel

Ownership: Private
Development stage: Commercial

Overview

Asiagel is a leading specialist in the manufacture and supply of premium culture media for microbiological applications. The company serves the life sciences sector by providing consistent, high-quality, and affordable ready-to-use and dehydrated culture media to support research, quality control, and industrial processes across healthcare, pharmaceutical, food & beverage, environmental testing, and other industries. It is recognized as a reputable player in the industrial microbiology market in Asia.

Industry: Chemicals & Materials

Beyond the preview

Go deeper on Asiagel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asiagel.

Explore the full profile